{
    "Trade/Device Name(s)": [
        "MicroScan Dried Gram Negative MIC/Combo Panels with Ciprofloxacin (Cp) (0.004 - 8 \u03bcg/mL)"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K193536",
    "Predicate Device Reference 510(k) Number(s)": [
        "K192355"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LTT",
        "JWY",
        "LRG",
        "LTW"
    ],
    "Summary Letter Date": "March 18, 2020",
    "Summary Letter Received Date": "December 20, 2019",
    "Submission Date": "December 02, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ciprofloxacin susceptibility"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of rapidly growing aerobic and facultative anaerobic gram-negative bacilli"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan instrumentation",
        "WalkAway system",
        "autoSCAN-4 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Dehydrated panel rehydration"
    ],
    "Methodologies": [
        "Minimum inhibitory concentration determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan Dried Gram Negative MIC/Combo Panels with Ciprofloxacin to determine antimicrobial susceptibility via MIC methods",
    "Indications for Use Summary": "Used to determine antimicrobial agent susceptibility of colonies of gram-negative bacilli to ciprofloxacin, by incubating inoculated panels and reading MIC visually or with MicroScan instruments.",
    "fda_folder": "Microbiology"
}